SPONSOR
Oana Danciu
Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Locoregional RecurrenceHormone Receptor-positive Breast CancerHER2-negative Breast Cancer
Oana Danciu is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Oana Danciu
How many clinical trials has Oana Danciu sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Oana Danciu, of which 1 are actively recruiting participants. These trials cover conditions including Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Oana Danciu research focus on?
Oana Danciu clinical trials span Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Oana Danciu clinical trial?
To participate in a Oana Danciu trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Oana Danciu trials with current recruitment status updated daily.
Clinical Trials by Oana Danciu
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology